The purpose of this study is to test the efficacy of a substance use disorder intervention delivered via a mobile application in an adult population during the COVID-19 pandemic. This study that will test the comparative efficacy of the mobile-app based substance use disorder program to reduce substance use relative to a wait list control condition, and explore between group differences on quality of life indices as well as retention and engagement during COVID-19.
Other: Woebot Substance Use Disorder
Woebot Substance Use Disorder is an automated conversational agent, available through a smartphone application, that delivers evidence-based psychotherapeutics, empathy, and emotional health psychoeducation.
Inclusion Criteria:
- All genders aged 18-65 years
- Access to a smartphone
- Available and committed to engage with app and complete assessments
- Be willing to provide email address (as this is how assessment incentives will be
distributed),
- Literate in English (as W-SUDs conversational and video materials will be in English).
Exclusion Criteria:
- Pregnancy (as W-SUDs will not be specifically developed to address the unique needs of
this population)
- History of severe drug/alcohol use
- History of opioid misuse without medication-assisted treatment
- Suicide attempt within the past year
- Opioid overdose within the past year
Stanford University
Palo Alto, California, United States